Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 279

Similar articles for PubMed (Select 9161660)

1.

Zolpidem: distinct from triazolam?

Lobo BL, Greene WL.

Ann Pharmacother. 1997 May;31(5):625-32. Review.

PMID:
9161660
2.
3.

Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.

Jonas JM, Coleman BS, Sheridan AQ, Kalinske RW.

J Clin Psychiatry. 1992 Dec;53 Suppl:19-31; discussion 32-3. Review.

PMID:
1336776
4.

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.

Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL.

Pharmacopsychiatry. 1994 Jul;27(4):166-75.

PMID:
7972349
5.

Zolpidem: a review of its use in the management of insomnia.

Swainston Harrison T, Keating GM.

CNS Drugs. 2005;19(1):65-89. Review.

PMID:
15651908
6.

Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.

Hoehns JD, Perry PJ.

Clin Pharm. 1993 Nov;12(11):814-28. Review. Erratum in: Clin Pharm 1993 Dec;12(12):881.

PMID:
8275648
7.

Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.

Rosenberg RP.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):49-56. Review.

PMID:
16517453
8.
9.
10.

Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.

Morgan PT, Kehne JH, Sprenger KJ, Malison RT.

J Sleep Res. 2010 Mar;19(1 Pt 2):157-64. doi: 10.1111/j.1365-2869.2009.00757.x. Epub 2009 Aug 13.

11.

Comment: zolpidem: distinct from triazolam?

Holt RJ, Allard S.

Ann Pharmacother. 1997 Nov;31(11):1408-13. No abstract available.

PMID:
9391705
12.

Minimal rebound insomnia after treatment with 10-mg zolpidem.

Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW.

Clin Neuropharmacol. 1997 Apr;20(2):116-25.

PMID:
9099463
13.

Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.

Rush CR, Baker RW, Wright K.

Psychopharmacology (Berl). 1999 Jun;144(3):220-33.

PMID:
10435388
14.
15.

Extended-release zolpidem: efficacy and tolerability profile.

Owen RT.

Drugs Today (Barc). 2006 Nov;42(11):721-7. Review.

PMID:
17171191
16.

A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.

Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F.

Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):117-23.

PMID:
11697572
17.
18.

Zolpidem for insomnia.

Greenblatt DJ, Roth T.

Expert Opin Pharmacother. 2012 Apr;13(6):879-93. doi: 10.1517/14656566.2012.667074. Epub 2012 Mar 19. Review.

PMID:
22424586
19.

The safety and tolerability of zolpidem--an update.

Darcourt G, Pringuey D, Sallière D, Lavoisy J.

J Psychopharmacol. 1999;13(1):81-93. Review.

PMID:
10221362
20.

Ramelteon: a novel approach in the treatment of insomnia.

Reynoldson JN, Elliott E Sr, Nelson LA.

Ann Pharmacother. 2008 Sep;42(9):1262-71. doi: 10.1345/aph.1K676. Epub 2008 Jul 23. Review.

PMID:
18648020
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk